TerminatedNCT04815018

Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pathnostics
Principal Investigator
Alan Wolfe, MD
Loyola University Chicago
Enrollment
185 target
Eligibility
60 years · All sexes
Timeline
20202021

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04815018 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials